Attached files
| file | filename |
|---|---|
| EX-31.1 - CERTIFICATION - Cyclo Therapeutics, Inc. | f10k2016ex31i_ctdholdingsinc.htm |
| 10-K - ANNUAL REPORT - Cyclo Therapeutics, Inc. | f10k2016_ctdholdingsinc.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with this Form 10-K of CTD Holdings, Inc. (the “Company”) for the fiscal year ended December 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, N. Scott Fine, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: March 17, 2017
| By: | /s/ N. Scott Fine | |
| N. Scott Fine | ||
| Chief Executive Officer | ||
| (principal
executive, financial and accounting officer) |